April 27 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said on Thursday its shareholders have approved a plan to distribute a gross dividend of 2,000 denars ($35.9/32.5 euro) per share for 2022, after skipping distribution for the previous year.